Cite
Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer
MLA
K.S. Grzankowski, et al. “Mitochondrial DNA in the Tumour Microenvironment Activates Neutrophils and Is Associated with Worse Outcomes in Patients with Advanced Epithelial Ovarian Cancer.” British Journal of Cancer, vol. 120, no. 2, Dec. 2018, pp. 207–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38122abe7c54e8bf0b23e24fea38523a&authtype=sso&custid=ns315887.
APA
K.S. Grzankowski, Zsuzsanna Környei, Rebeka Fekete, P.C. Mayor, Constantin F. Urban, Kelly L. Singel, Tiffany R. Emmons, Kunle Odunsi, Uma Muthukrishnan, Cynthia A. Leifer, Anthony C. D’Auria, Adam Denes, Kirsten B. Moysich, Kevin H. Eng, Kayla Morrell, Melissa J. Grimm, Nikolett Lénárt, Kiyoshi Itagaki, Carl J. Hauser, … A. Nazmul H. Khan. (2018). Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer. British Journal of Cancer, 120(2), 207–217.
Chicago
K.S. Grzankowski, Zsuzsanna Környei, Rebeka Fekete, P.C. Mayor, Constantin F. Urban, Kelly L. Singel, Tiffany R. Emmons, et al. 2018. “Mitochondrial DNA in the Tumour Microenvironment Activates Neutrophils and Is Associated with Worse Outcomes in Patients with Advanced Epithelial Ovarian Cancer.” British Journal of Cancer 120 (2): 207–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38122abe7c54e8bf0b23e24fea38523a&authtype=sso&custid=ns315887.